ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,438, issued on Dec. 16, was assigned to IP2IPO Innovations Ltd. (London).
"Compounds" was invented by Stephen Robert Bloom (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides novel compounds which are peptide hormone analogues, and which are useful in treating disorders such as diabetes and obesity. The compounds of the general sequence recited in the specification possess a tailored profile with regards to potency properties at the glucagon and GLP-1 receptors. With regard to in vivo properties, administration of example peptides of the invention have been shown, in animal models, to result in increased weight loss. Prefe...